Own experience of treatment by epoetin-a (Eralfon®) of chemotherapy induced anemia

Epoetin-α - is a medication, stimulating erythropoiesis. Is currently also used for the treatment of anemia induced by chemotherapy. Patients and methods. 124 patients with various solid tumors and a hemoglobin level <120 g/l received epoetin-α (Eralfon®) 10 000 ME or 12 000 ME three times a week. An evaluation of the increase in hemoglobin level was made, as well as an assessment of the pharmacoeconomic efficacy of various dosage forms. Results. It was noted that during chemotherapy with platinum, the hemoglobin level significantly increases with the use of an Eralfon® 12 000 ME. For patients weighing <70 kg, it is economically advantageous to use Eralfon® 10 000 ME, for patients ≥70 kg - Eralfon® 12 000 ME. The safety profile of both dosages is quite favorable.